Cite
MLA Citation
Stanley B Cohen et al.. “Efficacy and safety of tofacitinib modified-release 11 mg once daily plus methotrexate in adult patients with rheumatoid arthritis: 24-week open-label phase results from a phase 3b/4 methotrexate withdrawal non-inferiority study (ORAL Shift).” RMD open, vol. 7, no. 2, 2021, p. . http://access.bl.uk/ark:/81055/vdc_100132247234.0x000004